Dale A. Sander - 27 Aug 2024 Form 4 Insider Report for Humacyte, Inc. (HUMA)

Role
CFO and Chief Corp. Deve. Off.
Signature
/s/ Dale A. Sander
Issuer symbol
HUMA
Transactions as of
27 Aug 2024
Net transactions value
-$162,283
Form type
4
Filing time
29 Aug 2024, 18:45:12 UTC
Previous filing
12 Dec 2023
Next filing
20 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HUMA Common Stock Options Exercise $100,836 +39,389 +1969% $2.56 41,389 27 Aug 2024 Direct
transaction HUMA Common Stock Sale $263,119 -39,389 -95% $6.68 2,000 27 Aug 2024 Direct F1
holding HUMA Common Stock 20,600 27 Aug 2024 By spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HUMA Stock Options (right to buy) Options Exercise $0 -39,389 -100% $0.000000 0 27 Aug 2024 Common Stock 39,389 $2.56 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $6.67 to $6.725. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.